There are a lot of melons in the financial circle in 2021. The melons passed on the 17th are a little big, and all parties have responded. Fund Jun will take you to eat tonight. What’s the matter.
Chen long, former chief strategist of Netcom Zhongtai Securities Co.Ltd(600918) was arrested
also involves public fund managers?
On the 17th, a chat record in the group of financial circles swiped the screen. It is mentioned that Chen long, the former chief strategic analyst of Zhongtai Securities Co.Ltd(600918) , is currently locked up by the (police). It is rumored that they have a small group of more than 20 people to fry the stock of Huawei’s cars. Two Huawei employees were arrested first, and the police arrested all of them. Finally, the rumor also said that the general manager of the public fund quantification department responsible for receiving hot money chips was also investigated
What are the facts? On the 17th, Zhongtai Securities Co.Ltd(600918) , and the former general manager of the quantification Department of public funds responded.
According to the daily economic news report, Zhongtai Securities Co.Ltd(600918) former chief strategic analyst Chen Long was arrested. Some time ago, a policeman came to the company’s office to find him, and then resigned.
According to the latest information of China Securities Association, Chen long has registered his resignation with China Securities Association on November 15, 2021 and officially resigned from Zhongtai Securities Co.Ltd(600918) .
The official account of the Sino Thai strategy “crystal ball of investment in practice” shows that Chen Long has never published any research reports since November 10, 2021.
In response, Zhongtai Securities Co.Ltd(600918) mentioned that Chen long left the company on November 12 last year; In addition, the company is unaware of the information related to Chen Long transmitted online.
The other protagonist of the rumor is Jin Fangyi, the former public fund manager. In response, he said in his circle of friends that everything was normal in his work and life. Jin Fangyi said that he was currently starting a business and planned to set up a private fund, with people in Shanghai.
According to public information, Jin Fangyi is a doctor of economics, a financial risk manager and a chartered financial analyst. From January 2011 to March 2018, he successively served as senior researcher of quantification, investment manager of special account, head of quantitative investment department and fund manager in a joint venture fund management Co., Ltd. in Shanghai. During his tenure as a fund manager, he was once called the “four kings of quantification” by the market.
After joining another public fund in April 2018, he successively served as the head of quantitative investment department and the director of quantitative investment. On November 20, 2021, Jin Fangyi announced his departure,
In this regard, the relevant fund company replied that Jin Fangyi had left for several months and the company did not know about his personal situation. In addition, the company’s quantitative investment team currently operates normally, and the department heads and fund managers perform their duties normally.
crazy investors: earned several times in Andon Health Co.Ltd(002432)
want to donate money to a listed company
\u3000\u3000
On January 17, “demon stock” Andon Health Co.Ltd(002432) was directly sealed on the blackboard at 82.81 yuan / share, with a total market value of nearly 40 billion yuan.
Since the market started on November 15 last year, in 45 trading days, Andon Health Co.Ltd(002432) share price has soared from 6.9 yuan / share, up more than 1100%.
On the news side, Andon Health Co.Ltd(002432) announced on November 8 that its covid-19 antigen home self-test OTC kit has obtained emergency use authorization (EUA) in the United States. It is reported that the kit can quickly determine the virus in human nasal swab samples, give results in 15 minutes, and detect the Omicron variant. Subsequently, Andon Health Co.Ltd(002432) claimed to have obtained an order of 2 billion yuan from the United States.
After hours, Andon Health Co.Ltd(002432) issued a stock trading risk warning announcement, saying that the single month performance of the kit product does not represent the annual performance, and the historical performance of the product does not represent the future performance. The company believes that it is necessary to give risk warning again.
In the announcement, Andon Health Co.Ltd(002432) reminded investors from the risk of uncertainty in the development of epidemic situation in the United States, the risk of uncertainty in market competition, the risk of rationality of valuation model, the risk of reliability of information, logistics and transportation risk, quality risk, contract / order risk, etc.
The company said that in its previous announcement, the company mentioned the epidemic prevention related plans issued by the U.S. government, as well as the relevant policies, procurement and distribution plans and conditions of covid-19 antigen household self-test kit products. The relevant information and procurement involved in the above content are not only for Andon Health Co.Ltd(002432) . Investors are requested not to misunderstand the content and misinfer the changes it brings to the company’s performance.
At the same time, the announcement reminded that the company previously submitted the proposal on using family self-test box to realize Omicron covid-19 epidemic prevention 1 + 1 to Tianjin epidemic prevention and control headquarters. At present, it is uncertain whether the proposal will be adopted.
In terms of share price, Andon Health Co.Ltd(002432) said that at present, the company’s share price is at an all-time high and does not rule out the risk of falling in the future. The company’s share price is crazy, but the investors are even more crazy. Some investors have made several times of profits. They want to take out money to reward the company’s employees and make them work harder!
Shanxi Securities Co.Ltd(002500) : holding subsidiary Filed a lawsuit over LETV Securities Misrepresentation
On the 17th, Shanxi Securities Co.Ltd(002500) announced that Sino German securities, a holding subsidiary, was sued, involving an amount of 4.571 billion yuan.
The announcement said that on January 13, Sino German securities received a civil complaint served by the Beijing Financial court, the cause of action was a dispute over the liability for Securities Misrepresentation. Shanghai Junying asset management partnership (limited partnership) and other 2000 plaintiffs filed a civil lawsuit against LETV (LETV information technology (Beijing) Co., Ltd.) and other 21 defendants to the Beijing Financial court, requiring LETV to compensate for the investment loss of 4.571 billion yuan caused by its false statement, and requiring the other 20 defendants to bear joint and several liability.
The defendants of the lawsuit involved 14 natural persons such as LETV and Jia Yueting, 3 securities companies such as Sino German securities and 3 accounting firms.
LETV investors believe that LETV’s misrepresentation causes damage to its rights and interests, and require LETV to bear civil liability for misrepresentation infringement; Jia Yueting and other 14 natural persons shall be jointly and severally liable for false statements; Three securities companies including Sino German securities and three accounting firms are jointly and severally liable for failure to exercise due diligence and fail to find the financial fraud of LETV.
We originally told you to order LETV to pay the plaintiff infringement compensation for investment losses caused by false statements (including investment balance loss, stamp duty, commission and interest), totaling 4.571 billion yuan; Order the other 20 defendants except LETV to bear joint and several liability for the above losses of the plaintiff; Order the defendant to jointly bear all litigation costs of the case.
Shanxi Securities Co.Ltd(002500) said that the above-mentioned cases have not been heard and have not been adjudicated; There is uncertainty about its impact on the company’s profits in the current period or after the period.
